Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
F-IPF |
Human primary lung fibroblasts | Human | respiratory system | primary cell | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene EASY | publication | X. Deng et al., The Int. J. of Biochem. & Cell Biol., 213, 45: 1366– 1376, doi.org/10.1016/j.biocel.2013.04.003 | |||
EVLC2 |
Human umbilical vein endothelial cells | Human | vasculature | unknown | adherent | plasmid | Metafectene PRO | application note | ![]() |
||||
ESC |
Murine ESCs of the line R1 | Murine | unknown | stem cell | adherent | plasmid | stable transfection | Metafectene | publication | A. K. Shakhbazyan et al., Russian J. of Developmental Biol., 2013, 44 (6): 302–306, DOI: 10.1134/S1062360413060088 | |||
ES-D3 [D3] |
Mouse embryonic multipotent stem cell | ATCC CRL-1934 | Mouse | unknown | stem cell | adherent | plasmid | Metafectene PRO | publication | J. Suchánková et al., Europ. J. of Histochemistry, 2014; 58:2389, doi:10.4081/ejh.2014.2389 | Link | ||
ES-D3 [D3] |
Mouse embryonic multipotent stem cell | ATCC CRL-1934 | Mouse | unknown | stem cell | adherent | iron oxide | Imaging | Metafectene | publication | E. Küstermann et al., Contrast Media Mol. Imaging, 2008, 3: 27–37 | ||
ES-D3 |
Mouse pluripotent embryonic stem cell line | ATCC CRL-1934 | Mouse | unknown | stem cell | adherent | plasmid | Metafectene PRO | publication | M. Franek et al., Journal of Histochemistry & Cytochemistry, Nov 2016, 64, 669 - 686 | |||
EpiPC |
Mouse primary epicardial progenitor cells (culture from C57 mouse hearts) | Mouse | other | primary cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | H.-R. Yang, Master Thesis, 2013, Seoul National University | Link | ||
EMC |
Rat epicardial mesothelial cell line | Rat | other | cell line | adherent | plasmid | Metafectene | application note | ![]() |
||||
EL-4 |
Mouse T lymphoma cell line | ATCC TIB-39 | Mouse | immune system | cell line | suspension | plasmid | Metafectene | publication | A. Sahoo et al., J. Biol. Chem., Oct 2008; 283: 28860 - 28872 | Link | ||
EL-4 |
Mouse lymphoma T cell line | ATCC TIB-39 | Mouse | immune system | cell line | suspension | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | K. Ohl et al., Frontiers in Immunology, 2016, 7:618, doi: 10.3389/fimmu.2016.00618 | Link | |
EJ138 |
Human bladder carcinoma cell line | ECACC 85061108 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M.C. Burger et al., Int. J. of Oncology, 2012, 41: 235-241, DOI: 10.3892/ijo.2012.1446 | Link | |
EFO-27 |
Human ovary adenocarcinoma cell line (cisplatin resistant) | Human | genital tract | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
EFO-27 |
Human ovary adenocarcinoma cell line (cisplatin resistant) | Human | genital tract | cell line | adherent | plasmid | K2 Transfection System | publication | S. Dilruba et al., Cells, 2020, 9: 515, doi:10.3390/cells9020515 | Link | |||
EFO-27 |
Human ovary adenocarcinoma cell line (cisplatin resistant) | Human | genital tract | cell line | adherent | plasmid | stable transfection | K2 Transfection System | application note | ![]() |
|||
ECV-304 |
Human uroepithelial bladder carcinoma cell line | DSM ACC 310 | Human | urinary system | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
ECV-304 |
Human uroepithelial bladder carcinoma cell line | DSM ACC 310 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | J. Pelisek et al., J Mol Med (Berl), Nov 2002; 80(11): 724-36 | |||
E14/T |
Mouse embryonic stem cells | Mouse | unknown | stem cell | adherent | plasmid | Metafectene PRO | application note | ![]() |
||||
DU447 |
Human mammary adenocarcinoma cell line | Human | breast | cell line | iron oxide | Metafectene | publication | L. Matuszewski et al., Radiology, Apr 2005; 235: 155 - 161 | |||||
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | S.-B. Varda et al., 2012, EP 2 371 846 | Link | ||
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | V. Shoshan-Barmatz et al., 2014, US 8,648,045 (Patent) | Link | ||
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | plasmid | Metafectene PRO | publication | C. Morich, Dissertation, 2016, Georg-August University Göttingen | Link | ||
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. J. Choi et al., Cancer Res., Apr 2007; 67: 3654 - 3662 | Link | |
DLD-1 |
Human colon adenocarcinoma cell line | ATCC CCL-221 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | M. Masià-Balagué et al., J. Biol. Chem., Jun 2015; 290: 15197 - 15209 | |||
DLD-1 |
Human colon adenocarcinoma cell line | ATCC CCL-221 | Human | digestive organs | cell line | adherent | plasmid | CRISPR | Metafectene | publication | C. Emming, Dissertation, 2021, Ludwig-Maximilians-Universität München | Link |